CBD Consumer Health Market (2026 - 2033)

CBD Consumer Health Market Summary

The global CBD consumer health market size was valued at USD 25.7 billion in 2025 and is projected to grow from USD 29.8 billion in 2026 to USD 89.7 billion in 2033, at a CAGR of 17.1% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 65.0% in 2025, driven by the increasing number of positive government reforms for legalizing cannabidiol (CBD) in various regions worldwide. CBD consumer products are gaining significant acceptance due to rising awareness of their health benefits. Furthermore, the demand for hemp-derived CBD products is increasing globally due to the legalization of hemp in various countries.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Cannabidiol (CBD) has gained popularity in dietary supplements due to its health benefits and non-narcotic properties. Unlike Tetrahydrocannabinol (THC), CBD provides users with the advantages of cannabis without causing intoxication. Many people believe that CBD supplements offer more natural alternatives to prescription and over-the-counter medications for alleviating stiffness, pain, anxiety, stress, and various medical conditions. Manufacturers often prefer hemp-derived CBD because it contains a low concentration of THC. Regulatory frameworks for hemp cultivation and hemp-derived CBD products vary across countries, with permissions depending on the intended use, product category, and applicable licensing requirements. While some jurisdictions permit regulated hemp cultivation, the sale of CBD-containing foods, supplements, and other consumer health products may require separate authorization or remain restricted, influencing market access and commercialization opportunities.

The popularity of cannabidiol is also a reflection of shifting cultural perceptions and its recognized health benefits. Additionally, the innovative marketing and advertising strategies employed by leading companies have significantly increased product demand. As a result, there has been a noticeable expansion in consumer product options, including topicals, analgesics, edibles, oils, tinctures, and many more, driving substantial growth in this market. Moreover, growing awareness of the health benefits of CBD-infused products has increased consumers' willingness to purchase them, regardless of price.

In response to this surge in demand, mainstream retailers that once focused on non-CBD products are now shifting their attention to CBD-based offerings, attracted by higher profit margins and sales. For instance, in March 2023, CV Sciences, Inc., a U.S.-based wellness company that sells hemp extracts and other natural ingredients, announced the addition of +PlusCBD Daily Balance THC-Free Gummies and Softgels to its product line, providing consumers with the wellness benefits of CBD. Such developments have become increasingly common in recent years, fueled by legalization and a positive stance from health authorities and governments in the industry.

Analyst Perspective

The CBD consumer health market is evolving from an emerging wellness trend into a more structured and competitive health-focused category. Consumers are increasingly seeking products that support stress management, sleep, recovery, and overall well-being, while also expecting greater transparency around ingredient quality and product safety. Companies with strong brand credibility, reliable sourcing, and clear regulatory compliance strategies are likely to strengthen their market position. As the market matures, differentiation is expected to shift from broad product availability toward formulation quality, scientific backing, and consumer trust. In the coming years, businesses that can navigate evolving regulations while delivering consistent, effective products are likely to capture greater long-term value in this increasingly brand-driven wellness segment.

Product Insights

The nutraceuticals segment accounted for the largest revenue share, over 60.0%, in the CBD consumer health market in 2025. The growing adoption of CBD-infused nutraceutical products across applications such as weight management, sports nutrition, and health & wellness is driving growth in this segment. In addition, increasing consumer awareness of the health benefits of cannabidiol, shifting consumer preferences towards organic ingredients in dietary supplements, and favorable government reforms regarding CBD are key factors driving market expansion.

Moreover, an increase in the number of companies entering the CBD nutraceuticals space in recent years, the presence of lucrative investment opportunities, and a growing consumer base are likely to drive the demand for these products at a substantial pace over the forecast period. In January 2023, Medical Marijuana, Inc., the first publicly traded cannabis company in the U.S., launched two new full-spectrum products in Brazil under its subsidiary HempMeds Brasil. These competitively priced products are available in 30- and 60-mL jars, offering 3,000- 6,000 mg of CBD with significant cost savings for the rapidly expanding Brazilian market. The subsidiary's competitive pricing model aims to capitalize on this growing market.

Medical OTC products are expected to register a faster growth rate over the forecast period. This is owing to the increasing recognition of CBD's therapeutic benefits and the growing demand for self-care and wellness products. Medical OTC products, such as pain relief creams, balms, and supplements, have gained significant traction among consumers seeking natural alternatives for managing chronic pain, inflammation, and anxiety. The easing of regulatory restrictions and increasing availability of CBD-based products have further fueled segment growth. In addition, expanding distribution channels, including online platforms and retail stores, has increased the accessibility of medical OTC CBD products to consumers.

Distribution Channel Insights

In 2025, the retail pharmacies segment accounted for the highest revenue share in the global market. After the legalization of CBD products across various jurisdictions, the avenues for supplying them to consumers have expanded exponentially. This is mainly due to the higher consumption of cannabidiol-infused OTC medicines or products through retail pharmacies.

Meanwhile, the online stores segment is estimated to register the fastest CAGR during the forecast period, owing to the ease of product availability through online portals. A majority of companies have launched online portals for purchasing CBD-based products. This has increased the visibility of cannabidiol products to consumers, even in remote locations. For instance, in May 2024, Capital CBD American Shaman, a Texas-based manufacturer of CBD edibles and topicals, among other products, announced the launch of its e-commerce website to boost its online sales. Companies are also collaborating with specialty stores, such as Sephora and GNC, to drive both online and offline sales.

Regional Insights

North America dominated the market for CBD consumer health products, accounting for over 65.0% of revenue in 2025. This is attributed to the higher concentration of CBD companies and relaxed laws regarding the utilization of such products in this region. In addition, an increase in CBD consumption, a rise in awareness of its health benefits, the growing popularity of CBD-based food and health products, and the introduction of the 2018 Farm Bill, which legalized hemp cultivation and the manufacturing of hemp-derived products in the U.S., are major factors driving regional demand.

To learn more about this report, Download Free Sample Report

Increasing acceptance and adoption of cannabis-derived products among consumers has been a major growth driver for the U.S. market. The decriminalization of these products has led to an increased adoption among a larger consumer base. For instance, the U.S. Food and Drug Administration (FDA) has approved the use of cannabis-derived drug product Epidiolex (Cannabidiol) and three synthetic CBD-derived products: Marinol (dronabinol), Cesamet (nabilone), and Syndros (dronabinol), for medical purposes. A well-developed infrastructure for crop production and distribution has facilitated the efficient production and supply of CBD products.

Asia Pacific CBD Consumer Health Market Trends

The Asia Pacific CBD consumer health market is estimated to register the fastest CAGR during the forecast period. This is attributed to the increasing awareness of the health benefits of CBD, especially for chronic pain, anxiety, insomnia, epilepsy, and skin conditions. Moreover, the acceptance of CBD products in major Asian economies such as Thailand, South Korea, Japan, and India, which creates a favorable environment for the industry and consumers, is another factor propelling regional industry growth.

The CBD consumer health market in China held a substantial revenue share in 2025, owing to rising CBD-based healthcare initiatives and increased spending capacity of middle-class consumers. China’s growing economy and high disposable income have allowed consumers to spend more on health and wellness products, thus creating demand for CBD nutraceuticals and OTC products. In addition, a large proportion of China's aging population is a major driver of CBD nutraceuticals, with a focus on senior health solutions such as pain relief and easy-to-use applications such as CBD tinctures, capsules, and softgels.

Europe CBD Consumer Health Market Trends

Europe is anticipated to witness a notable CAGR during the forecast period, driven by rising consumer awareness and positive perceptions of CBD and its products, as well as strategic investments by major companies operating in the region. Moreover, the growing adoption and authorization of CBD oil in countries such as Switzerland, Germany, and the UK are expected to drive the regional market. For instance, in May 2026, the UK's Food Standards Agency (FSA) published an article stating that it continued to advance its CBD novel food authorization program. They have accelerated the program's operations as they have seen an increase in consumer demand for CBD oils and supplements.

Germany’s progressive stance on medical cannabis has fostered a conducive regulatory environment for CBD-based products. The legalization of cannabis for medical purposes in Germany has accelerated research and development activities in the CBD domain, leading to a surge in product innovation and availability. Regulatory authorities in the country have relaxed their restrictions on the possession of cannabis. For instance, the Federal Ministry of Food and Agriculture (BLE) has relaxed its regulations on cannabis and allowed the opening of Cannabis Social Clubs (CSC) for the regulated purchase of cannabis. Germany’s position as a European powerhouse has attracted substantial investments in the CBD sector.

Key CBD Consumer Health Market Companies Insights

Some key companies involved in the CBD consumer health market include Medical Marijuana, Inc., CV Sciences, Inc., and ENDOCA, among others.

• Medical Marijuana Inc. is a California-based U.S. company that develops, manufactures, and sells hemp-derived CBD products through its subsidiaries. For instance, the company sells CBD-derived products in Brazil through its subsidiary HempMeds Brasil. The company offers various CBD-derived products, including oils, tinctures, and capsules. CBD Gummies offered by the company are among the company’s most sought-after items.
• CV Sciences, Inc. is a U.S.-based specialty pharmaceuticals and consumer wellness company that develops, manufactures, and sells nutraceuticals and herbal-based CBD products. The company sells its products primarily through two brands: +PlusCBD and +PlusCBD Pet, which include oils, softgels, capsules, topicals, and gummies. In addition, the company sells pain-relief products, including CBD Pain Relief Arthritis Cream, Muscle Cream, Balms, Sprays, and Roll-Ons.

Key CBD Consumer Health Companies

The following key companies have been profiled for this study on the CBD consumer health market:

• Elixinol

• ENDOCA

• NuLeaf Naturals, LLC

• Kazmira

• Charlotte's Web, Inc.

• Joy Organics

• The Cronos Group

• Medical Marijuana, Inc.

• CV Sciences, Inc.

Recent Developments

• In August 2026, Joy Organics expanded its USDA-certified organic, THC-free CBD gummy range by introducing a 50 mg CBD-per-serving option and a new sour apple flavor, alongside its existing strawberry lemonade flavor. The launch broadens its high-strength CBD wellness offering and provides consumers with additional product choices.

• In January 2026, cbdMD, Inc. announced the acquisition of substantially all assets of Bluebird Botanicals, a long-established brand in the CBD industry. The acquisition was aimed at expanding cbdMD’s consumer reach, strengthening its product portfolio, and enhancing revenue opportunities through Bluebird Botanicals’ established customer base and market presence.

• In June 2024, Charlotte’s Web, Inc. expanded its retail presence by launching its CBD topical products in more than 800 Walmart stores across multiple U.S. states, including Illinois, Texas, California, Pennsylvania, and Florida. The expansion improved product accessibility and broadened the company’s reach within the growing consumer CBD market.

Global CBD Consumer Health Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities across each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global CBD consumer health market report based on product, distribution channel, and region:

• Product Outlook (Revenue, USD Billion, 2021 - 2033)

  • Medical OTC Products                

    • CBD Analgesic Products      

    • CBD Dermatology Products 

    • CBD Mental Health Products          

    • CBD Sleeping Aids Products

    • Other OTC Products             

  • Nutraceuticals                

    • CBD Vitamins and Dietary Supplements (VDS)     

    • CBD Sports Nutrition

    • CBD Weight Management and Wellbeing 

• Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)

  • Online Stores

  • Retail Stores

  • Retail Pharmacies

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • India

    • China

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait